Speakers

With over 25 years of pharmaceutical industry experience, I am an experienced medical leader with a passion for Rare Disease and Infectious Diseases, including HIV and viral hepatitis. Breadth of experience extends to global clinical research and development. I rise to the challenge of international assignments and have achieved results in US, Europe and Asia by quickly adapting to the culture and applying learnings across the medical organization. I currently serve as the Vice President International Medical and Board Member at Amicus Therapeutics UK Ltd, where I oversee the medical organization for the ex-US Amicus affiliates and distributors. I am responsible for delivering medical activities for Fabry Disease and Pompe Disease, two rare and life-threatening metabolic disorders. I have extensive experience in launching new specialized medicines and making them safely available for patients in multiple geographies, including countries with unique regulatory, technical, compliance, and legal frameworks. I have led successful launches of multiple products in infectious diseases, HIV, Hepatitis B and C, Diabetes Type II, Cardiovascular, Immuno-Oncology, Hematology/Oncology, and most recently in Pompe Disease. I have worked on products with various therapeutic modalities, such as small molecule (NDA), recombinant proteins (BLA), and gene therapy. I seek to partner with cross-functional industry leaders to deliver corporate goals, shape culture, and enhance employee engagement. I empower my team members to improve organizational quality and to achieve results through executing a shared and aligned strategy. I set ambitious but realistic goals, challenge the status quo, and enhance medical affairs capabilities to achieve improved patient outcomes.